Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...
Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...
The "Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's ...
Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...
Asia-Pacific promises rapid growth, while increasing tobacco use and investments in oncology centers drive demand for innovative treatments Non-Small Cell Lung Cancer (NSCLC) Market Non-Small Cell ...
New research suggests heavy marijuana smoking may raise the risk of lung cancer risk, as well as head and neck cancer.
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution ...
Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...
Researchers reported at the 2026 European Lung Cancer Congress that Hernexeos (zongertinib) led to high response rates and ...
Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for two drugs for the treatment of adults ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results